These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
378 related articles for article (PubMed ID: 16454536)
1. The prevalence of potential drug-drug interactions in patients with heart failure at hospital discharge. Straubhaar B; Krähenbühl S; Schlienger RG Drug Saf; 2006; 29(1):79-90. PubMed ID: 16454536 [TBL] [Abstract][Full Text] [Related]
2. Potential drug-drug interactions in the medication of medical patients at hospital discharge. Egger SS; Drewe J; Schlienger RG Eur J Clin Pharmacol; 2003 Mar; 58(11):773-8. PubMed ID: 12634985 [TBL] [Abstract][Full Text] [Related]
3. Prevalence and risk of potential cytochrome P450-mediated drug-drug interactions in older hospitalized patients with polypharmacy. Doan J; Zakrzewski-Jakubiak H; Roy J; Turgeon J; Tannenbaum C Ann Pharmacother; 2013 Mar; 47(3):324-32. PubMed ID: 23482734 [TBL] [Abstract][Full Text] [Related]
4. Polypharmacy, aging and potential drug-drug interactions in outpatients in Taiwan: a retrospective computerized screening study. Lin CF; Wang CY; Bai CH Drugs Aging; 2011 Mar; 28(3):219-25. PubMed ID: 21250763 [TBL] [Abstract][Full Text] [Related]
5. Prevalence of drug-drug interactions in older people before and after hospital admission: analysis from the OPERAM trial. Zerah L; Henrard S; Wilting I; O'Mahony D; Rodondi N; Dalleur O; Dalton K; Knol W; Haschke M; Spinewine A BMC Geriatr; 2021 Oct; 21(1):571. PubMed ID: 34663238 [TBL] [Abstract][Full Text] [Related]
6. Clinical-pharmacist intervention reduces clinically relevant drug-drug interactions in patients with heart failure: A randomized, double-blind, controlled trial. Roblek T; Deticek A; Leskovar B; Suskovic S; Horvat M; Belic A; Mrhar A; Lainscak M Int J Cardiol; 2016 Jan; 203():647-52. PubMed ID: 26580349 [TBL] [Abstract][Full Text] [Related]
7. Prevalence of drug-drug interactions at hospital entry and during hospital stay of patients in internal medicine. Vonbach P; Dubied A; Krähenbühl S; Beer JH Eur J Intern Med; 2008 Oct; 19(6):413-20. PubMed ID: 18848174 [TBL] [Abstract][Full Text] [Related]
8. Potential drug-drug interactions and polypharmacy in institutionalized elderly patients in a public hospital in Brazil. Castilho ECD; Reis AMM; Borges TL; Siqueira LDC; Miasso AI J Psychiatr Ment Health Nurs; 2018 Feb; 25(1):3-13. PubMed ID: 28892271 [TBL] [Abstract][Full Text] [Related]
9. Potential drug-drug interactions in hospitalized patients with chronic heart failure and chronic obstructive pulmonary disease. Roblek T; Trobec K; Mrhar A; Lainscak M Arch Med Sci; 2014 Oct; 10(5):920-32. PubMed ID: 25395943 [TBL] [Abstract][Full Text] [Related]
10. Prevalence and pattern of potential drug-drug interactions among chronic kidney disease patients in south-western Nigeria. Olumuyiwa JF; Akinwumi AA; Ademola OA; Oluwole BA; Ibiene EO Niger Postgrad Med J; 2017; 24(2):88-92. PubMed ID: 28762362 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of Drug Interactions in Hospitalized Patients with Respiratory Disorders in Greece. Spanakis M; Ioannou P; Tzalis S; Chouzouri F; Patelarou E; Kofteridis DP; Antoniou KM; Schiza SE; Patelarou A; Tzanakis N Adv Respir Med; 2023 Feb; 91(1):74-92. PubMed ID: 36825942 [No Abstract] [Full Text] [Related]
13. Drug-drug interactions in a cohort of hospitalized elderly patients. Pasina L; Djade CD; Nobili A; Tettamanti M; Franchi C; Salerno F; Corrao S; Marengoni A; Iorio A; Marcucci M; Mannucci P Pharmacoepidemiol Drug Saf; 2013 Oct; 22(10):1054-60. PubMed ID: 24038765 [TBL] [Abstract][Full Text] [Related]
14. [Prevalence of potential drug-drug interactions in ambulatory patients with statin therapy]. Rätz Bravo AE; Tchambaz L; Krähenbuhl-Melcher A; Hess L; Schlienger RG; Krähenbühl S Praxis (Bern 1994); 2006 Feb; 95(5):139-46. PubMed ID: 16509450 [TBL] [Abstract][Full Text] [Related]
15. The role of the clinical pharmacist in the prevention of potential drug interactions in geriatric heart failure patients. Georgiev KD; Hvarchanova N; Georgieva M; Kanazirev B Int J Clin Pharm; 2019 Dec; 41(6):1555-1561. PubMed ID: 31595450 [TBL] [Abstract][Full Text] [Related]
16. Prevalence of the coprescription of clinically important interacting drug combinations involving oral anticancer agents in Singapore: a retrospective database study. Ko Y; Tan SL; Chan A; Wong YP; Yong WP; Ng RC; Lim SW; Salim A Clin Ther; 2012 Aug; 34(8):1696-704. PubMed ID: 22795926 [TBL] [Abstract][Full Text] [Related]
17. Comorbidity, Polytherapy, and Drug Interactions in a Neurological Context: An Example of a Multidisciplinary Approach to Promote the Rational Use of Drugs. Busa G; Burlina A; Damuzzo V; Chiumente M; Palozzo AC J Pharm Pract; 2018 Feb; 31(1):58-65. PubMed ID: 29278992 [TBL] [Abstract][Full Text] [Related]
18. Clinical relevance of drug-drug interactions in hospitalized dermatology patients. Ganeva M; Gancheva T; Troeva J; Kiriyak N; Hristakieva E Adv Clin Exp Med; 2013; 22(4):555-63. PubMed ID: 23986216 [TBL] [Abstract][Full Text] [Related]
19. Hospital admissions/visits associated with drug-drug interactions: a systematic review and meta-analysis. Dechanont S; Maphanta S; Butthum B; Kongkaew C Pharmacoepidemiol Drug Saf; 2014 May; 23(5):489-97. PubMed ID: 24616171 [TBL] [Abstract][Full Text] [Related]
20. Drug-drug interactions and their harmful effects in hospitalised patients: a systematic review and meta-analysis. Zheng WY; Richardson LC; Li L; Day RO; Westbrook JI; Baysari MT Eur J Clin Pharmacol; 2018 Jan; 74(1):15-27. PubMed ID: 29058038 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]